Intravenous Dofetilide, a Class III Antiarrhythmic Agent, for the Termination of Sustained Atrial Fibrillation or Flutter

Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.

Sanguinetti, M. C., & Jurkiewicz, N. K. (1990) · The Journal of General Physiology · doi:10.1085/jgp.96.1.195 · Cited by 1,466 · see citing works

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

Coplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., & Chalmers, T. C. (1990) · Circulation · doi:10.1161/01.cir.82.4.1106 · Cited by 944 · see citing works

Digoxin for Converting Recent-Onset Atrial Fibrillation to Sinus Rhythm

Falk, R. H., Knowlton, A. A., Bernard, S. A., Gotlieb, N. E., & Battinelli, N. J. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-503 · Cited by 335 · see citing works

Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide.

Carmeliet, E. E. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10827-6 · Cited by 322 · see citing works

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension

Capucci, A., Lenzi, T., Boriani, G., Trisolino, G., Binetti, N., Cavazza, M., Fontana, G. A., & Magnani, B. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91392-h · Cited by 227 · see citing works

Cesium chloride-induced long QT syndrome: demonstration of afterdepolarizations and triggered activity in vivo.

Levine, J. H., SPEAR, J. F., Guarnieri, T., Weisfeldt, M. L., LANGEN, C. D. D., Becker, L. C., & Moore, E. N. (1985) · Circulation · doi:10.1161/01.cir.72.5.1092 · Cited by 205 · see citing works

UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.

Gwilt, M., Arrowsmith, J. E., Blackburn, K. J., Burges, R. A., Cross, P. E., Dalrymple, H. W., & Higgins, A. J. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23172-x · Cited by 187 · see citing works

Rate-Dependent Class III Antiarrhythmic Action, Negative Chronotropy, and Positive Inotropy of a Novel Ik Blocking Drug, UK-68,798

Tande, P. M., Bjørnstad, H., Yang, T., & Refsum, H. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199009000-00008 · Cited by 177 · see citing works

Validation of double-spike electrograms as markers of conduction delay or block in atrial flutter

Cosío, F. G., Arribas, F., Barbero, J. M., Kallmeyer, C., & Goicolea, A. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91065-x · Cited by 155 · see citing works

Sotalol, hypokalaemia, syncope, and torsade de pointes.

McKibbin, J. K., Pocock, W. A., Barlow, J. B., Millar, R. N. S., & Obel, I. W. P. (1984) · Heart · doi:10.1136/hrt.51.2.157 · Cited by 150 · see citing works

A Comparison of Some Approximate Confidence Intervals for the Binomial Parameter

Ghosh, B. K. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481051 · Cited by 130 · see citing works

Control of cardiac arrhythmias by selective lengthening of repolarization: Theoretic considerations and clinical observations

Singh, B. N., & Nademanee, K. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90629-5 · Cited by 125 · see citing works

Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset

Bianconi, L., BOCCADAMO, R., Pappalardo, A., Gentili, C., & Pistolese, M. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90530-4 · Cited by 123 · see citing works

Quinidine-induced long qtu interval and torsade de pointes: Role of bradycardia-dependent early afterdepolarizations

El‐Sherif, N., Bekheit, S.-S., & Henkin, R. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90082-x · Cited by 105 · see citing works

Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.

Spinelli, W., & Hoffman, B. F. (1989) · Circulation Research · doi:10.1161/01.res.65.6.1565 · Cited by 87 · see citing works

Acute pharmacologic conversion of atrial fibrillation and flutter: The role of flecainide, propafenone, and verapamil

Kingma, J. H., & SUTTORP, M. J. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91079-j · Cited by 87 · see citing works

Procaine Amide

Kayden, H. J., Brodie, B. B., & Steele, J. M. (1957) · Circulation · doi:10.1161/01.cir.15.1.118 · Cited by 83 · see citing works

Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug

CRIJNS, H. J. G. M., VAN GELDER, I. C., KINGMA, J. H., DUNSELMAN, P. H. J. M., GOSSELINK, A. T. M., & LIE, K. I. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060402 · Cited by 76 · cited 7× · see citing works

Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter

SUTTORP, M. J., Polak, P. E., Hof, A. W. J. V. ’., Rasmussen, H. S., Dunselman, P. H. J. M., & Kingma, J. H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90247-v · Cited by 70 · see citing works

Chemical cardioversion of atrial fibrillation with intravenous dofetilide

Sedgwick, M. L., Lip, G. Y. H., Rae, A. P., & Cobbe, S. M. (1995) · International Journal of Cardiology · doi:10.1016/0167-5273(95)02284-4 · Cited by 65 · see citing works

When is QT prolongation antiarrhythmic and when is it proarrhythmic?

Singh, B. N. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90059-3 · Cited by 64 · see citing works

Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm

Olshansky, B., Okumura, K., Hess, P. G., Henthorn, R. W., & Waldo, A. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90102-7 · Cited by 57 · see citing works

Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: Observations on the role of trial design and implications of drug-related mortality

Reimold, S. C., Chalmers, T. C., Berlin, J. A., & Antman, E. M. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90974-z · Cited by 48 · see citing works

Pharmacodynamics and Pharmacokinetics of the Class III Antiarrhythmic Agent Dofetilide (UK-68,798) in Humans

Tham, T., MacLennan, B. A., Burke, M. T., & Harron, D. W. G. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199303000-00024 · Cited by 45 · see citing works

Class III Antiarrhythmic Action and Inotropy

Mortensen, E., Yang, T., & Refsum, H. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199202000-00010 · Cited by 31 · see citing works

Comparison in the Same Patient of Aberrant Conduction and Bundle Branch Reentry After Dofetilide, a New Selective Class III Antiarrhythmic Agent

Crijns, H. J. G. M., Kingma, J. H., Gosselink, A. T. M., & Lie, K. I. (1993) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1993.tb04575.x · Cited by 23 · see citing works

Sequential bilateral bundle branch block during dofetilide, a new class III antiarrhythmic agent, in a patient with atrial fibrillation

CRIJNS, H. J. G. M., KINGMA, J. H., GOSSELINK, A. T. M., DALRYMPLE, H. W., De LANGEN, C. D. J., & LIE, K. (1993) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1993.tb01283.x · Cited by 18 · see citing works

To prolong refractoriness or to delay conduction (or both)?

Janse, M. J. (1992) · European Heart Journal · doi:10.1093/eurheartj/13.suppl_f.14 · Cited by 17 · see citing works

Boston City Hospital

LYMAN, J. C. (1876) · New England Journal of Medicine · doi:10.1056/nejm187610050951408 · Cited by 13 · see citing works

UK-68,798

Prous, J., & Castañer, J. (1991) · Drugs of the Future · doi:10.1358/dof.1991.016.06.140759 · Cited by 7 · see citing works

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,225 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418 · see citing works

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): <i>Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society</i>

Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403 · see citing works

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,358 · see citing works

2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)

Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,278 · see citing works

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,157 · see citing works

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 921 · see citing works

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859 · see citing works

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · EP Europace · doi:10.1093/europace/eul097 · Cited by 663 · see citing works

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary

Authors Task Force Members, Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 645 · see citing works

Part 8: Advanced Life Support

Morrison, L. J., Deakin, C. D., Morley, P. T., Callaway, C. W., Kerber, R. E., Kronick, S. L., Lavonas, E. J., Link, M. S., Neumar, R. W., Otto, C. W., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971051 · Cited by 609 · see citing works

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Circulation · doi:10.1161/circ.104.17.2118 · Cited by 607 · see citing works

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2983 · Cited by 489 · see citing works

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.018 · Cited by 465 · see citing works

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177031 · Cited by 341 · see citing works

Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation

Roy, D., Pratt, C. M., Torp-Pedersen, C. T., Wyse, D. G., Toft, E. S., Juul‐Möller, S., Nielsen, T., Rasmussen, S., Stiell, I. G., Coutu, B., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.723866 · Cited by 321 · see citing works

Atrial fibrillation: current knowledge and recommendations for management*1

Lévy, S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1050 · Cited by 321 · see citing works

Electrical Remodeling of the Human Atrium: Similar Effects in Patients With Chronic Atrial Fibrillation and Atrial Flutter

Franz, M. R., Karasik, P. L., Li, C., Moubarak, J., & Chavez, M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00385-9 · Cited by 301 · see citing works

Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography

McNamara, R. L., Tamariz, L. J., Segal, J. B., & Bass, E. B. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-12-200312160-00012 · Cited by 211 · see citing works

Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes

Darpö, B. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90009-4 · Cited by 203 · see citing works

Part 8: Advanced life support

Deakin, C. D., Morrison, L. J., Morley, P. T., Callaway, C. W., Kerber, R. E., Kronick, S. L., Lavonas, E. J., Link, M. S., Neumar, R. W., Otto, C. W., et al. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.027 · Cited by 201 · see citing works

Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation

Vos, M. A., Golitsyn, S. R., Stangl, K., Ruda, M. Y., Van Wijk, L., Harry, J. D., Perry, K. T., Touboul, P., Steinbeck, G., & Wellens, H. J. J. (1998) · Heart · doi:10.1136/hrt.79.6.568 · Cited by 200 · see citing works

Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment

Hogue, C. W. J., & Hyder, M. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)01267-9 · Cited by 194 · see citing works

European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)

Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188 · see citing works

Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis

Chevalier, P., Durand-Dubief, A., Burri, H., Cucherat, M., Kirkorian, G., & Touboul, P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02705-5 · Cited by 184 · see citing works

“Early” Class III Drugs for the Treatment of Atrial Fibrillation

Blaauw, Y., Gögelein, H., Tieleman, R. G., van Hunnik, A., Schotten, U., & Allessie, M. A. (2004) · Circulation · doi:10.1161/01.cir.0000143050.22291.2e · Cited by 173 · see citing works

Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study

Bianconi, L. (2000) · European Heart Journal · doi:10.1053/euhj.1999.2039 · Cited by 126 · see citing works

Droperidol Lengthens Cardiac Repolarization due to Block of the Rapid Component of the Delayed Rectifier Potassium Current

Drolet, B., Zhang, S., Deschênes, D., Rail, J., NADEAU, S., Zhou, Z., January, C. T., & Turgeon, J. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00224.x · Cited by 116 · see citing works

Dofetilide

Mounsey, J. P., & Dimarco, J. (2000) · Circulation · doi:10.1161/01.cir.102.21.2665 · Cited by 116 · see citing works

Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trial

Nørgaard, B. L., Wachtell, K., Christensen, P. D., Madsen, B., Johansen, J. B., Christiansen, E. H., Graff, O. X., & Simonsen, E. H. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70363-7 · Cited by 111 · see citing works

Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected transposition of the great arteries

Hornung, T., Bernard, E. J., JAEGGI, E. T., Howman-Giles, R. B., Celermajer, D. S., & Hawker, R. E. (1998) · Heart · doi:10.1136/hrt.80.4.322 · Cited by 107 · see citing works

Contrasting Efficacy of Dofetilide in Differing Experimental Models of Atrial Fibrillation

Li, D., Benardeau, A. M., & Nattel, S. (2000) · Circulation · doi:10.1161/01.cir.102.1.104 · Cited by 107 · see citing works

Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

Merino, J. L., Tamargo, J. L., Blomström‐Lundqvist, C., Boriani, G., Crijns, H. J. G. M., Dobrev, D., Goette, A., Hohnloser, S. H., Naccarelli, G. V., Reiffel, J. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf076 · Cited by 105 · see citing works

Pharmacological Cardioversion of Atrial Fibrillation

Boriani, G., Diemberger, I., Biffi, M., Martignani, C., & Branzi, A. (2004) · Drugs · doi:10.2165/00003495-200464240-00003 · Cited by 91 · see citing works

Exaggerated QT prolongation after cardioversion of atrial fibrillation

Choy, A. M. J., Darbar, D., Dell’Orto, S., & Roden, D. M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00226-0 · Cited by 89 · see citing works

Current Antiarrhythmic Drugs

Singh, B. N. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00674.x · Cited by 85 · see citing works

Conversion of Recent‐Onset Atrial Fibrillation with Intravenous Amiodarone: A Meta‐Analysis of Randomized Controlled Trials

Hilleman, D. E., & Spinler, S. A. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.1.66.33492 · Cited by 84 · see citing works

Recent developments in atrial fibrillation

Iqbal, M. B., Taneja, A. K., Lip, G. Y. H., & Flather, M. D. (2005) · BMJ · doi:10.1136/bmj.330.7485.238 · Cited by 72 · see citing works

Electrophysiological and antiarrhythmic effects of the novel I Kur channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I Kr blockers dofetilide, azimilide, d,l-sotalol and ibutilide

Knobloch, K., Brendel, J., Peukert, S., Rosenstein, B., Busch, A. E., & WIRTH, K. J. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0599-x · Cited by 72 · see citing works

New Approaches to Atrial Fibrillation Management

Nattel, S., Khairy, P., Roy, D., Thibault, B., Guerra, P. G., Talajic, M. R., & Dubuc, M. (2002) · Drugs · doi:10.2165/00003495-200262160-00005 · Cited by 72 · see citing works

Guías de práctica clínica de la Sociedad Española de Cardiología en arritmias cardíacas

Garrote, J. A., Huerta, E. M., Moreno, O. M., Peinado, R., Álvarez, L. P., Granell, R. R., & Viñolas, X. (2001) · Revista Española de Cardiología · doi:10.1016/s0300-8932(01)76313-0 · Cited by 70 · see citing works

Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide

Abel, S., Nichols, D. J., Brearley, C. J., & Eve, M. D. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00114.x · Cited by 68 · see citing works

Antiarrhythmic Drugs: A Reorientation in Light of Recent Developments in the Control of Disorders of Rhythm

Singh, B. N. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00147-7 · Cited by 66 · see citing works

Electrocardiographic differentiation of atrial flutter from atrial fibrillation by physicians

Knight, B. P., Michaud, G. F., Strickberger, S. A., & Morady, F. (1999) · Journal of Electrocardiology · doi:10.1016/s0022-0736(99)90002-x · Cited by 57 · see citing works

Clinical Experience with Dofetilide in the Treatment of Patients with Atrial Fibrillation

Prystowsky, E. N., Freeland, S., Branyas, N. A., Rardon, D. P., Fogel, R. I., Padanilam, B. J., & RIPPY, J. S. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.90402.x · Cited by 56 · see citing works

Rhythm Management in Atrial Fibrillation—with a Primary Emphasis on Pharmacological Therapy: Part 2

Costeas, C. A., Kassotis, J., Blitzer, M. L., & Reiffel, J. A. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00132.x · Cited by 56 · see citing works

Dofetilide: a new class III antiarrhythmic agent

Roukoz, H., & Saliba, W. I. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.1.9 · Cited by 54 · see citing works

Management of the Older Person With Atrial Fibrillation

Aronow, W. S. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.6.m352 · Cited by 53 · see citing works

Antiarrhythmic agents and proarrhythmia

Chaudhry, G. M., & Haffajee, C. I. (2000) · Critical Care Medicine · doi:10.1097/00003246-200010001-00008 · Cited by 53 · see citing works

Dofetilide, a New Class III Antiarrhythmic Agent

Lenz, T. L., & Hilleman, D. E. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.9.776.35208 · Cited by 51 · see citing works

A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease

Boriani, G. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2679 · Cited by 50 · see citing works

Role of abnormal repolarization in the mechanism of cardiac arrhythmia

Osadchii, O. E. (2017) · Acta Physiologica · doi:10.1111/apha.12902 · Cited by 49 · see citing works

Electropharmacologic Effects of Class I and Class III Antiarrhythmia Drugs on Typical Atrial Flutter

Tai, C. T., Chen, S., Feng, A.-N., Yu, W., Chen, Y., & Chang, M.-S. (1998) · Circulation · doi:10.1161/01.cir.97.19.1935 · Cited by 49 · see citing works

The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosing

Allen, M. J., Nichols, D. J., & Oliver, S. D. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00243.x · Cited by 47 · see citing works

Accuracy of Diagnosing Atrial Flutter and Atrial Fibrillation From a Surface Electrocardiogram by Hospital Physicians: Analysis of Data From Internal Medicine Departments

Shiyovich, A., Wolak, A., Yacobovich, L., Grosbard, A., & Katz, A. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e73fcf · Cited by 47 · see citing works

Pharmacologic management of atrial fibrillation: Current therapeutic strategies

Lévy, S. (2001) · American Heart Journal · doi:10.1067/mhj.2001.109952 · Cited by 46 · see citing works

Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter

Lindeboom, J.-E., Kingma, J. H., Crijns, H. J. G. M., & Dunselman, P. H. J. M. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00927-3 · Cited by 46 · see citing works

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation31This document was approved by the American College of Cardiology Board of Trustees in August 2001, the American Heart Association Science Advisory and Coordinating Committee in August 2001, and the European Society of Cardiology Board and Committee for Practice Guidelines and Policy Conferences in August 2001.32When citing this document, the American College of Cardiology, the American Heart Association, and the European Society of Cardiology would appreciate the following citation format: Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:XX-XX.33This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the American Heart Association (www.americanheart.org), the European Society of Cardiology (www.escardio.org), and the North American Society of Pacing and Electrophysiology (www.naspe.org). Single reprints of this document (the complete Guidelines) to be published in the mid-October issue of the European Heart Journal are available by calling +44.207.424.4200 or +44.207.424.4389, faxing +44.207.424.4433, or writing Harcourt Publishers Ltd, European Heart Journal, ESC Guidelines – Reprints, 32 Jamestown Road, London, NW1 7BY, United Kingdom. Single reprints of the shorter version (Executive Summary and Summary of Recommendations) published in the October issue of the Journal of the American College of Cardiology and the October issue of Circulation, are available for $5.00 each by calling 800-253-4636 (US only) or by writing the Resource Center, American College of Cardiology, 9111 Old Georgetown Road, Bethesda, Maryland 20814. To purchase bulk reprints specify version and reprint number (Executive Summary 71-0208; full text 71-0209) up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail: pubauth@heart.org.

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01586-8 · Cited by 46 · see citing works

Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation

Nair, M., George, L. K., & Koshy, S. K. G. (2011) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2011.01.080096 · Cited by 44 · see citing works

New advances in class III antiarrhythmic drug therapy

Sager, P. T. (1999) · Current Opinion in Cardiology · doi:10.1097/00001573-199901000-00004 · Cited by 43 · see citing works

Dofetilide

McClellan, K. J., & Markham, A. (1999) · Drugs · doi:10.2165/00003495-199958060-00007 · Cited by 42 · see citing works

Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial

Holst, A. G., Tomcsányi, J., Vestbjerg, B., Grunnet, M., Sørensen, U. S., Diness, J. G., Bentzen, B. H., Edvardsson, N. G., Hohnloser, S. H., Bhatt, D. L., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02679-9 · Cited by 39 · see citing works

Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

Kraft, M., Büscher, A., Wiedmann, F., L’hoste, Y., Haefeli, W. E., Frey, N., Katus, H. A., & Schmidt, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.638445 · Cited by 31 · see citing works

Postrepolarization Refractoriness as a Potential Anti–Atrial Fibrillation Mechanism of Pilsicainide, a Pure Sodium Channel Blocker with Slow Recovery Kinetics

Kanki, H., Mitamura, H., Takatsuki, S., Sueyoshi, K., Shinagawa, K., Sato, T., & Ogawa, S. (1998) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007758217189 · Cited by 32 · see citing works

A Multiple Ion Channel Blocker, NIP‐142, for the Treatment of Atrial Fibrillation

Tanaka, H., & Hashimoto, N. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00025.x · Cited by 31 · see citing works

The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data

Tunblad, K., Lindbom, L., McFadyen, L., Jonsson, E. N., Marshall, S. F., & Karlsson, M. O. (2008) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-008-9099-z · Cited by 30 · see citing works

Effects of dofetilide on cardiovascular tissues from normo- and hypertensive rats

Doggrell, S. A., & Nand, V. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778862 · Cited by 30 · see citing works

Dofetilide: A new pure class III antiarrhythmic agent

Falk, R. H., & DeCara, J. M. (2000) · American Heart Journal · doi:10.1067/mhj.2000.110457 · Cited by 30 · see citing works

New advances in class III antiarrhythmic drug therapy

Sager, P. T. (2000) · Current Opinion in Cardiology · doi:10.1097/00001573-200001000-00006 · Cited by 30 · see citing works

Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter

Banchs, J. E., Wolbrette, D. L., Samii, S. M., Penny-Peterson, E., Patel, P. P., Young, S. K., Gonzalez, M. D., & Naccarelli, G. V. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9290-6 · Cited by 28 · see citing works

Differential effects of dofetilide, amiodarone, and class Ic drugs on left and right atrial refractoriness and left atrial vulnerability in pigs

WIRTH, K. J., & Knobloch, K. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000328 · Cited by 28 · see citing works

Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 28 · see citing works

Special Problems With Antiarrhythmic Drug in the Elderly: Safety, Tolerability, and Efficacy

Dayer, M., & Hardman, S. M. C. (2002) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2002.0069.x · Cited by 27 · see citing works

Therapy of Atrial Fibrillation: Rhythm Control Versus Rate Control

CARLSSON, J., NEUZNER, J., & Rosenberg, Y. (2000) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2000.tb00861.x · Cited by 27 · see citing works

Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization

Singh, B. N., Mody, F. V., Lopez, B. M., & Sarma, J. S. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00718-3 · Cited by 27 · see citing works

Ranolazine: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias

Shenasa, M., Assadi, H. R., Heidary, S., & Shenasa, H. (2016) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2016.02.011 · Cited by 26 · see citing works

The class III antiarrhythmic drugs dofetilide and sotalol prevent AF induction by atrial premature complexes at doses that fail to terminate AF

Derakhchan, K. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00320-5 · Cited by 25 · see citing works

Dofetilide: A Class III-Specific Antiarrhythmic Agent

Kalus, J. S., & Mauro, V. F. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19185 · Cited by 25 · see citing works

Clinical Efficacy of Dofetilide for the Treatment of Atrial Tachyarrhythmias in Adults with Congenital Heart Disease

Banchs, J. E., Baquero, G. A., Nickolaus, M. J., Wolbrette, D. L., Kelleman, J. J., Samii, S. M., Ting, J. G., Penny-Peterson, E., Davidson, W. R., Young, S. K., et al. (2013) · Congenital Heart Disease · doi:10.1111/chd.12129 · Cited by 24 · see citing works

MANAGEMENT OF ATRIAL FIBRILLATION, VENTRICULAR ARRHYTHMIAS AND PACEMAKERS IN OLDER PERSONS: Series Editor: Wilbert S. Aronow, MD: Management of the Older Person With Atrial Fibrillation

Aronow, W. S. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01602.x · Cited by 23 · see citing works

Controlling Cardiac Arrhythmias: An Overview With a Historical Perspective

Singh, B. N. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00709-1 · Cited by 23 · see citing works

Dofetilide: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias

Shenasa, F., & Shenasa, M. (2016) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2016.02.006 · Cited by 20 · see citing works

Dofetilide Promotes Repolarization Abnormalities in Perfused Guinea-pig Heart

Osadchii, O. E. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6405-1 · Cited by 20 · see citing works

ACC/AHA/ESC: Guías de Práctica Clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida

Informe del Grupo de Trabajo para la elaboración de guías de práctica clínica del American College of Cardiology y de la American Heart Association, del Comité de Guías de Práctica Clínica de la Sociedad Europea de Cardiología (comité de redacción para la revisión de la Guía de práctica clínica sobre el manejo de pacientes con fibrilación auricular, 2., & Desarrollado en colaboración con las asociaciones European Heart Rhythm Association y Heart Rhythm Society (2006) · Revista Española de Cardiología · doi:10.1157/13096583 · Cited by 20 · see citing works

Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter

Maykov, E. B., Yuricheva, Y. A., Mironov, N. Y., Sokolov, S. F., Sp, G., Розенштраух, Л. В., & Chazov, E. I. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh201587138-48 · Cited by 19 · see citing works

Electrophysiological Effects of Dofetilide in an In Vitro Model of “Border Zone” Between Normal and Ischemic/Reperfused Myocardium

Rouet, R., Picard, S., Libersa, C., Ghadanfar, M. M., Alabaster, C. T., & Gérard, J. (2000) · Circulation · doi:10.1161/01.cir.101.1.86 · Cited by 18 · see citing works

Effect of Nifekalant for Acute Conversion of Atrial Flutter: The Possible Termination Mechanism of Typical Atrial Flutter

Morita, N., Tanaka, K., Yodogawa, K., Hayashi, M., Akutsu, K., Yamamoto, T., Satoh, N., Kobayashi, Y., Katoh, T., & Takano, T. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00846.x · Cited by 17 · see citing works

A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today?

Wolbrette, D. L., HUSSAIN, S. K., Maraj, I., & Naccarelli, G. V. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418784288 · Cited by 18 · see citing works

Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility

Choudhury, A., & Lip, G. Y. H. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.841 · Cited by 18 · see citing works

Intrapericardial Ibutilide Administration Fails to Terminate Pacing-Induced Sustained Atrial Fibrillation in Dogs

Vereckei, A., Gorski, J. C., Ujhelyi, M. R., Mehra, R., & Zipes, D. P. (2004) · Cardiovascular Drugs and Therapy · doi:10.1023/b:card.0000041246.13952.b4 · Cited by 17 · see citing works

Typical Atrial Flutter: A Practical Review

Johner, N., Namdar, M., & Shah, D. C. (2025) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16542 · Cited by 16 · see citing works

Antiarrhythmic Drugs and Strategies

Opie, L. H., Dimarco, J., & Gersh, B. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-6158-8.50013-7 · Cited by 16 · see citing works

Clinical and Electrophysiologic Effects of Dofetilide in Patients with Supraventricular Tachyarrhythmias

Kobayashi, Y., Atarashi, H., Ino, T., Kuruma, A., Nomura, A., Saitoh, H., & Hayakawa, H. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199709000-00015 · Cited by 16 · see citing works

Antiarrhythmic drugs and strategies

Nattel, S., Gersh, B. J., & Opie, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-3322-4.00017-x · Cited by 15 · see citing works

Atrial Fibrillation

Aronow, W. S. (2002) · Heart Disease · doi:10.1097/00132580-200203000-00006 · Cited by 15 · see citing works

Dofetilide: a new drug to control cardiac arrhythmia

Elming, H., Brendorp, B., Pedersen, O. D., Køber, L., Elming, H., & Torp-Petersen, C. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.6.973 · Cited by 15 · see citing works

Efficacy of Nifekalant in Patients With Wolff‐Parkinson‐White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings

Hu, J., Yu, J., Chen, Q., Hu, J., Huang, Q., Xia, Z., Xia, Z., Ju, Z., Yuan, P., Fan, S. L., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012511 · Cited by 14 · see citing works

Prevention of and Medical Therapy for Atrial Arrhythmias in Heart Failure

Khand, A. U., Cleland, J. G. F., & DEEDWANIA, P. C. (2002) · Heart Failure Reviews · doi:10.1023/a:1020097728178 · Cited by 14 · see citing works

Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter

Lindeboom, J.-E., Kingma, J. H., Crijns, H. J. G. M., & Dunselman, P. H. J. M. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00927-3 · Cited by 46 · see citing works

Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trial

Nørgaard, B. L., Wachtell, K., Christensen, P. D., Madsen, B., Johansen, J. B., Christiansen, E. H., Graff, O. X., & Simonsen, E. H. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70363-7 · Cited by 111 · see citing works

Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after

Christiansen, H., & Christiansen, N. F. (1997)

Dofetilide

McClellan, K. J., & Markham, A. (1999) · Drugs · doi:10.2165/00003495-199958060-00007 · Cited by 42 · see citing works

Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery

Frost, L., Mortensen, P. E., Tingleff, J., Platou, E. S., Christiansen, E. H., & Christiansen, N. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02856-2 · Cited by 70 · see citing works